Mark W. Lingen to Molecular Targeted Therapy
This is a "connection" page, showing publications Mark W. Lingen has written about Molecular Targeted Therapy.
Connection Strength
0.110
-
AXL Is a Logical Molecular Target in Head and Neck Squamous Cell Carcinoma. Clin Cancer Res. 2015 Jun 01; 21(11):2601-12.
Score: 0.110
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.